We compared the efficacy of gene transfer in vitro and in CFTR to mice and rats. We observed a lack of positive correvivo using various formulations of DNA-lipid complexes lation between those DNA-EDMPC formulations that delivbased on the novel cationic lipid EDMPC (1,2-dimyristoylered DNA most efficiently in vitro and those that worked best sn-glycero-3-ethylphosphocholine, chloride salt). In vitro in vivo. Intralobar DNA delivery to rodents mediated by studies analyzed delivery of marker genes to four estab-EDMPC was efficient. The high level of gene delivery by lished cell lines, including two of pulmonary origin. The in DNA-EDMPC formulations demonstrates that efficient lipidvivo analysis used intralobar delivery of marker genes and mediated gene transfer to the lung is possible.
Introduction method of formulation of the lipid-DNA complex, partiWe favor the idea that safe and simple methods can be cularly the DNA to lipid ratio, is critical, since it will confound to deliver DNA efficiently to target cells of interest tribute to the particle size and surface charge of the comfor the purpose of gene therapy. To minimize biological plex. 4 Furthermore, although lipid-DNA complexes are hazards and to facilitate mass production of reagents, most often tested in vitro for convenience, the difference nonviral methods of delivery are attractive. Among the between tissue culture conditions and in vivo conditions methods currently under intense development is the use raises the question of whether the same formulations will of cationic lipids complexed to DNA to mediate intrabe optimal in both situations. cellular delivery of genes of interest. This method holds
We have addressed these issues by studying a novel promise for gene therapy of cystic fibrosis, because it may cationic lipid, EDMPC (1,2-dimyristoyl-sn-glycero-3-allow sufficient delivery of DNA carrying the wild-type ethylphosphocholine, chloride salt), that appeared to cystic fibrosis transmembrane conductance regulator have an enhanced ability to deliver DNA to pulmonary (CFTR) gene 1 to the lung epithelium to ameliorate the tissues. To address systematically the question of symptoms of the disease. 2, 3 whether there is a correlation between the formulations The mechanism whereby cationic lipids facilitate DNA of lipid-DNA complexes that transfect well in vitro and delivery is not fully understood. The lipid appears to those which lead to successful gene delivery in vivo, we induce condensation of the DNA through charge interacconducted a series of experiments comparing many tions, followed by interaction with the cell membrane, DNA-lipid formulations made with EDMPC. In vitro leading to endocytosis. Intrinsic fusigenic activity of the studies were carried out in a variety of established cell lipid may lead to release of DNA into the cytoplasm, with lines, including two of pulmonary origin. A corresponda portion of the DNA arriving in the nucleus. 4 Many ing in vivo analysis was done using intralobar delivery of chemically different lipids with significant ability to the complexes to the lungs of mice and rats. The results deliver DNA to cells in vitro and in vivo have been indicate that the formulations that were optimal in vitro reported. 4 Such lipids have been used in in vivo studies, differed from those that worked best in vivo. However, including those directed at treatment of melanoma by efficient delivery was obtained in both cases. direct injection 5 and of cystic fibrosis by intralobar instillation or aerosol delivery. 2, 3 While these studies showed delivery of DNA to the intended tissue, increased
Results

efficiency of delivery was clearly desirable. Increased efficiency could result from chemically different lipids
In vitro expression of reporter genes possessing increased ability to perform the steps The cationic lipid EDMPC was mixed in a 1:1 molar ratio with a neutral lipid, either cholesterol or 1,2-dioleoyl phosphatidylethanolamine (DOPE). To test systematically the efficiency of EDMPC, DNA at different concen- Figure  ture denotes the DNA to cationic lipid ratio (mg for DNA and mm for the lipid) followed by the DNA concentration 2a). The formulations that transfected the least efficiently in COS cells were those with a 3:1 ratio of DNA to lipid, in mg/ml.
The efficacy of each formulation was tested in vitro in with a DNA concentration of 0.625 mg/ml. The most efficient formulations were EDMPC-DOPE at a 1:1 DNA several cell types. Cell lines such as COS and 293, which are commonly used in gene transfer assays and in recomto lipid ratio at 1.5 mg/ml DNA and a 2:1 ratio at 2 mg/ml DNA. Frequently the EDMPC-DOPE 1:1; 1 binant protein production, were tested as were established cell lines of pulmonary origin. Expression of a mg/ml DNA complexes precipitated. During the transfection, EDMPC-cholesterol at 1:1; 1.5 mg/ml DNA and reporter gene transfected into these cell lines was compared with expression in two lung cell lines that may be 1:1; 2 mg/ml DNA also often precipitated upon addition to the media. In general, complexes that precipitated more relevant model systems for cystic fibrosis. The first series of experiments used the E. coli lacZ gene on plaswere quite efficient, suggesting a role for phagocytosis in the mechanism of uptake in vitro. mid pMB10 (Figure 1a ) as a reporter in transfections of diameter in the range of 200-290 nm. The 1:10 formulation yielded the best expression levels, up to 6 mU of ␤-galactosidase activity/mg of protein. This formulation tended to form precipitates once added to the cells, again suggesting that efficient complexes in vitro could be precipitate in nature.
The above in vitro studies used COS and 293 cells which are commonly used for transfection studies. Since cells of pulmonary origin could behave differently and may be more relevant models for gene therapy of cystic fibrosis, the transfection experiments were repeated with two cell lines, A549 and H441, derived from lung tumors. A549 and H441 cells were transfected with complexes made with pMB10 and EDMPC-cholesterol or EDMPC-DOPE. The complexes tested included formulations with equal parts of DNA and lipid (1:1) and formulations containing an excess of DNA (2:1 and 3:1). These results are shown in Figure 3a and b. While there is some variation in efficiency of these complexes, the overall pattern for transfection with lung cells was similar to that seen with the COS cells. Formulations made with a DNA to lipid ratio of 3:1; 0.625 mg/ml transfected the least well, while The same formulations were made using p4119 DNA carrying the chloramphenicol acetyl transferase gene (CAT, Figure 1b ) and tested in 293 cells. Complexes made with p4119 DNA were divided for testing in vitro ( Figure  2b ) and in vivo by intralobar delivery (see below). 293 Cells were transfected, and an ELISA was used to determine CAT expression levels. The most efficient were EDMPC-cholesterol formulations for in vitro transfection made at a DNA to lipid ratio of 1:1, with 1.5 or 2 mg/ml DNA. For these two formulations up to 50 ng of CAT protein/mg of total protein was expressed. The least efficient complexes in this in vitro analysis were the 2:1; 1 mg/ml DNA and 3:1; 0.625 mg/ml DNA formulations. 2c). These formulations yielded complexes with a mean 986 1:1; 1 mg/ml DNA and 1:1; 1.5 mg/ml DNA were best values of 800-900 mU CAT activity/mg of protein in the for in vitro delivery. The formulations made with DOPE left lung. Significant CAT levels, 103 mU CAT generally yielded higher expression. This result is conactivity/mg protein, were seen using water as the delivsistent with membrane fusion, in addition to phagoery vehicle (Figure 4a ). Since the DOPE formulations can cytosis, playing a role in the mechanism of uptake in be rather unstable, the remaining experiments were pervitro. 6 formed using EDMPC-cholesterol.
We analyzed formulations made with excess EDMPCExpression of reporter genes in rodent lungs cholesterol in rats and found that formulations made at For the in vivo testing, the same EDMPC-cholesterol and the 1:10 DNA:cationic lipid ratio were not efficient in vivo, EDMPC-DOPE formulations prepared using p4119 CAT even though they were among the best in vitro. The for-DNA that were tested for gene delivery in vitro ( Figure  mulation 1:10; 0.625 mg/ml DNA, which worked well in 2b) were administered in vivo by intralobar delivery to vitro yielded expression levels of 0.07 mU in vivo. rodents ( Figure 4 ). For delivery to the left lung of rats, 0.3
As further positive controls for efficient delivery, ml of DNA-lipid complex were administered, and CAT additional complexes at 3:1; 0.625 mg/ml DNA containactivity was measured in lungs and trachea after 24 h. ing p4119 CAT DNA and EDMPC-cholesterol were The best in vivo expression was consistently seen with delivered by intralobar instillation to mice. CAT enzyme a 3:1; 0.625 mg/ml DNA formulation, made with either assays performed on tissues from animals transfected EDMPC-cholesterol or EDMPC-DOPE (Figure 4a ). The with these complexes confirmed high levels of CAT 3:1; 0.625 mg/ml formulation using EDMPC-cholesterol expression in the left lung. Expression levels in mice folyielded greater than 1 × 10 4 mU CAT activity/mg prolowing intralobar delivery were similar to the levels of tein. Given the specific activity of the CAT enzyme expression in rats ( Figure 4b ). (Promega, Madison, WI, USA), this value represented approximately 100 ng CAT protein/mg of total protein.
Formulations made with EDMPC-cholesterol at a ratio of
Immunohistochemistry of CAT gene expression in 2:1, with either 1 or 2 mg/ml DNA, gave expression at mouse and rat lungs Immunohistochemistry was performed for detection of CAT in mouse and rat lung. Mice were dosed by intralobar instillation of 100 l of the 3:1; 0.625 mg/ml EDMPCcholesterol formulation made with p4119 and rats were dosed with 300 l. Tissues were harvested and prepared for cryosectioning 48 h after treatment. Figure 5 shows immunohistochemical detection of CAT in 4 m thick sections of mouse lung using an anti-CAT-digoxigenin primary antibody followed by an anti-digoxigenin goldlabeled secondary antibody and silver enhancement. Tissues at × 100 are shown in panels a-f. Sections from a control animal treated with 5% dextrose in water are shown in a and b. Panels d and f are bright field, while panels c and e are phase contrast. These are × 200 magnification of samples from a p4119-treated animal. In the treated animals there were numerous fields of cells which stained positive for CAT. In the rat, based on morphology and double labeling of CAT expression and cell type markers, the majority of cells staining positive for CAT are alveolar type I cells. Figure 6 shows double labeling of CAT expression and type I or type II cells in 5 m thick cryosections. CAT expression, a and b, was detected with anti-CAT digoxigenin followed by anti-digoxigenin fluorescein. Type II cells, c (arrows), were detected with anti-serum to rat surfactant protein (a kind gift from Dr Gurmukh Singh) followed by a rabbit 7-amino-4-methylcioumarin-3-acetic acid (AMCA)-labeled secondary antibody. Type I cells, Figure 6d , were detected by the binding of biotinylated Lycopersicon esculentum lectin 7
Figure 4 Intralobar delivery of CAT-EDMPC complexes in rodents.
followed by AMCA-labeled avidin. Corresponding phase cells being positive, could be found. RT-PCR analysis of CFTR expression in rodent lungs mRNA-generated product (159 bp) by virtue of primers which span the 5′ intron present in the pMB113 vector. In order to model gene therapy experiments for treatment of cystic fibrosis, we studied delivery of pMB113
When these primers were used on pMB113 plasmid DNA, a band of 501 bp was detected. The presence of plasmid DNA carrying the CFTR gene. Following intralobar delivery of 3:1; 0.625 mg/ml EDMPC-cholesterol spliced mRNA, specific for pMB113 resulted in a band of 159 bp. The five mice treated with CFTR DNA were all made with pMB113 to rodents, expression of the CFTR cDNA was assayed at the level of mRNA. Control anipositive for vector-specific mRNA by this analysis as indicated by the presence of a 159 bp band (Figure 7b , mals were treated with either a similar amount of 5% dextrose ( Figure 7, lane 1) or CAT expression vector lanes 3-7). This band was isolated from the gel and shown by DNA sequence analysis to be the predicted ( Figure 7, lane 2) . The presence of intact RNA in tissue samples from mice was first verified by using mouse ␤-product of properly spliced message from pMB113. When assayed for expression of vector-specific CFTR 2 microglobulin primers (Figure 7a) . The samples were then tested with vector-specific primers. The vectormRNA, samples from both the dextrose-treated ( Figure  7b , lane 1) and CAT-treated ( Figure 7b , lane 2) animals specific primers were designed to distinguish between a vector-generated DNA PCR product (501 bp) and a were negative. has continued, it has become evident that lipid com-
Discussion
pounds with an increased efficiency would be of value.
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Efficient delivery of DNA to the pulmonary epithelium Some efforts have focused on the ability of these new is needed for gene therapy of diseases such as cystic lipid formulations to transfect cells in vitro. 16 fibrosis. Several studies have shown in vivo delivery of In this report a direct comparison of the relationship CFTR cDNA by adenovirus to be problematic. [8] [9] [10] Thus between in vitro transfection and in vivo gene expression alternative means of in vivo gene delivery to the nasal is described. In these studies there was a lack of positive epithelium or lung have been developed. [11] [12] [13] These correlation between the complexes which were efficient efforts using lipid-DNA-mediated gene transfer have in vitro compared with those which were efficient in vivo. succeeded in the delivery of CFTR cDNA to rodents 2, 3, 12, 13 Others have also observed that in vitro analysis for gene and have proceeded into clinical trials. 14, 15 As this work delivery is not predictive of expression in vivo. [17] [18] [19] [20] Even the use of cell lines of pulmonary origin did not provide particles must form prior to the addition to cells. 25 It is believed that the various precipitation methods of gene a predictive model system for in vivo use. 21 It remains to be seen whether the use of polarized airway epithelial transfer, such as DEAE-dextran and calcium phosphate co-precipitation, act through phagocytosis. cells, capable of forming intact junctions, might provide a more reasonable in vitro screening paradigm. 22 In In vivo gene transfer may take place via alternative pathways. Logan et al 17 measured 200-300 pg of CAT addition to there being a lack of correlation between efficiency of in vitro and in vivo gene transfer, there was protein/mg of lung protein following intratracheal delivery using DMRIE:DOPE. Lee et al 20 recently reported an also a welcome lack of correspondence between compounds that were toxic in vitro and their apparent lack extensive study which tested numerous novel lipids. The best two formulations discussed in this work yielded 300 of toxicity in vivo. 17, 23, 24 The EDMPC complexes described in this report that ng and 1 g of CAT protein in an entire lung. All lipids tested by Lee et al were seen to be toxic both in vitro and delivered DNA efficiently to cells in vitro were physically different from the complexes that were most efficient in in vivo. Water has been shown active in this gene transfer assay 20, 24 although it may to lead to osmotic cellular vivo. Complexes that were larger and had optical densities of greater than 0.1 up to 0.3 (measured at 400 nm) shock. 26 Meyer et al 24 showed that intratracheal delivery of DNA was best with water alone and was not facilitated performed better in vitro, while smaller complexes with optical densities of less than 0.1 were optimal in vivo. The by the use of a variety of lipids. The most efficient EDMPC formulations for in vivo mean diameter of the best complexes for in vivo expression was less than 200 nm. Conversely, the comdelivery were EDMPC-cholesterol and EDMPC-DOPE at 3:1; 0.625 mg/ml DNA. These formulations yielded as plexes leading to the highest expression levels in vitro were generally greater than 200 nm. Pulmonary cell lines much as 20 000 mU of CAT activity/mg total protein.
From direct measurement of intralobar delivery with the were studied to determine whether there was any difference between transfection of lung cell lines compared p4119 CAT plasmid, we observed expression levels in the range of 50-200 ng/mg of protein or 1.5-6 g in total with cell lines used for recombinant protein production such as COS and 293 cells. While the A549 cells translung The EDMPC formulations described in this report were an order of magnitude higher in expression than fected well with some of these formulations, there was still no positive correlation between complexes that DNA in water alone. In additional studies, cationic liposome complexes have been shown to be stable to nebulizexpressed best in vitro (1:1; 1 mg/ml) and those that expressed best in vivo (3:1; 0.625 mg/ml). Complexes ation, while DNA in water was degraded by this procedure (Ref. 27 and Megabios, unpublished results). were also studied that contained an excess lipid to DNA ratio. Formulations tested for in vitro efficacy in transfectTherefore, in the aerosol delivery envisioned for treatment of pulmonary disease such as cystic fibrosis gene ing 293 cells included formulations with an excess of lipid to DNA. These formulations were inefficient in in vitro therapy, DNA complexed with cationic lipids would be far superior to DNA in water. transfection, with the exception of the 1:10 formulation. This formulation tended to precipitate and did transfect
Immunohistochemistry was used to visualize transfected cells 48 h following intralobar delivery. No staincells well in vitro. In general, the complexes that were larger performed better in vitro, and precipitated coming was observed in control animals instilled with 5% dextrose in water ( Figure 5 ) or in the right lungs of aniplexes were best. This result is similar to in vitro transfection with the calcium phosphate co-precipitation techmals instilled with lipid-DNA complexes. No nonspecific staining was seen in the left lungs of lipid-DNA-treated nique; for gene transfer to be successful in vitro, visible animals when irrelevant digoxigenin-labeled primary Transfections A cationic lipid, 1,2-dimyristoyl-sn-glycero-3-ethylphosantibodies were used. These results are consistent with the idea that DNA is reaching the nuclei of transfected phocholine, chloride salt (EDMPC), manufactured by Sigma (St Louis, MO, USA) for Megabios Corporation pulmonary epithelial cells. Based on morphology and double labeling of reporter gene expression and cell type was used. Liposomes were prepared by sonication of EDMPC and cholesterol (Sigma) or EDMPC and DOPE markers, the majority of expressing cells in the rat are alveolar type I cells. Since this intralobar delivery system (Sigma) at a 1:1 molar ratio. A sample of each DNA-lipid complex was retained for evaluation by size and optical deposits the complexes into the deep lung, the primary cells exposed to the complexes include alveolar type I density. These values are given in Table 1 . Sizing was performed on a Nicomp 370 submicron particle sizer and type II cells and alveolar macrophages. The majority of the cells expressing CAT levels detectable by immu-(software C370, version 12.1) (Nicomp, Santa Barbara, CA, USA). Each sample was allowed to equilibrate for 2 nohistochemistry were the type I cells based on morphology, they were flat and exhibited large surface area min before analysis, and sizing proceeded for 5 min for each sample. lining the alveolar wall, and on double staining of sections with antibodies to CAT and with either type I, type Plasmid DNAs (p4119 for CAT; pMB10 for lacZ and pMB113 for CFTR) were used for complexing with the II cell markers.
Expression in vivo was also followed by detection of liposomes. Expression vector pMB10 contains the human cytomegalovirus (hCMV) promoter 28 the 5′ SV40 late messenger RNA levels for the CFTR gene. Techniques were standardized to allow isolation of intact mRNA intron, the lacZ gene and the SV40 early region polyA 29 ( Figure 1a) . p4119 contains the hCMV promoter 28,30 the from mouse lungs. This step was verified with the use of ␤-2 microglobulin. Once samples were verified for the 5′ preproinsulin intron, 31 the chloramphenicol acetyl transferase (CAT) gene 32 and the SV40 early region poly presence of intact mRNA, vector-specific primers were used to analyze transgene expression. The set of 5′ pri-A (see Figure 1b) . pMB113 contains CFTR DNA sequences 33 under control of the hCMV promoter (Figure mers, demonstrated to detect CFTR mRNA specifically, was also used successfully to monitor CFTR expression 1c). These vectors also contain ampicillin or tetracycline resistance genes and a prokaryotic plasmid origin of repfollowing lipid-DNA delivery. In the experiment shown here, 100% of the animals treated with CFTR DNA were lication. The plasmids were purified by alkaline lysis and phenol/chloroform extraction. positive. In general, we find that greater than 75% of all treated animals tested for vector-specific mRNA are
For in vitro transfections, cells were split into six-well plates and 18 h later were washed with 2 ml of 1 × PBS, positive.
The efficiency of EDMPC formulations in vivo is high re-fed with 1 ml of serum-free medium, and incubated for 1 h. Complexes (200 l) were then added and left to when compared with the results obtained in vivo by others. 17, 24 The level of expression seen with EDMPC is transfect for 4 h. These conditions were found to be the most efficient for transfecting cells in vitro with a minicomparable with a low level of adenovirus infection 20 and similar to that seen by Lee et al. 20 However, unlike mum of cell death. Cells were then washed with 2 ml 1 × PBS and re-fed with 2 ml of regular medium. Cells were the lipids described in this latter study, lungs treated harvested 24 h later for ␤-galactosidase activity assay or with EDMPC-DNA complexes showed a visible lack of CAT ELISA (Boehringer Mannheim) and protein assays. inflammation upon examination at high power implying A chromogenic assay was used to assay ␤-galactosidase a lack of toxicity. This high level of expression and the for the in vitro experiments. All expression data were ability to monitor CFTR expression easily by mRNA levstandardized per milligram of soluble protein present in els suggests that lipid-DNA formulations made with each sample as assayed by the Bradford assay kit. EDMPC can be used for efficient gene delivery to the lungs for the treatment of a variety of pulmonary disIn vivo delivery eases including cystic fibrosis.
Sprague Dawley female rats with a body weight of 100 g were used. For intralobar instillation into the lobar lung region, rats were anesthetized with Metofane
Materials and methods
(methoxyflurane, Mallinckrodt, Phillipsburg, NJ, USA). The rats were then placed supine at an angle of approximately 30°and 300 l of lipid-DNA complex were gently Cell lines injected into the left main bronchus using a syringe Four cell lines were obtained from the American Type attached to an intubation needle (Perfektum stainless Culture Collection (Rockville, MD, USA): 293, a transforsteel animal intubation needles; PGC Scientifics, Gaimed human embryonic kidney cell line (ATCC No. 1573-thersburg, MD, USA). The animal was maintained in the CRL); COS1, a SV40 transformed African Green monkey left side down position exposed to 100% oxygen for 2-3 cell line (ATCC No. 1650-CRL); A-549, a human lung carmin until fully awake. 26 Rats were monitored for coughcinoma cell line (ATCC No. 174-HTB); and NCI-H441, a ing and regurgitation. The latter never occurred. As human lung papillary adenocarcinoma line (ATCC No.
further proof of the lack of regurgitation, five rats 10809). All cell lines were maintained in DMEM F12 received Evan's blue solution to ascertain the location of medium (GIBCO-BRL, Gaithersburg, MD, USA). This instillation. The blue dye was uniformly found in one medium was supplemented with 10% fetal bovine serum lung and never in the esophagus or stomach. Rats were (GIBCO-BRL), 100 units penicillin-streptomycin allowed to recover for 48 h before death. Pathogen-free (GIBCO-BRL), and 2 mm glutamine (GIBCO-BRL). Cells mice, 25 g, were similarly instilled with 100 l of lipidwere maintained at a subconfluent density by splitting DNA complexes. Control animals were instilled with 5% dextrose in water. twice weekly.
The dosing formulations for this study comprised tant protein 7 diluted in blocking buffer. The sections were washed then incubated with anti-digoxigenin fluorescein DNA-lipid complexes containing either EDMPC-cholesterol or EDMPC-DOPE liposomes and an expression vecand AMCA-labeled goat anti-rabbit (Vector Laboratories) diluted in blocking buffer. Sections were then washed tor. DNA:cationic lipid ratios are shown in Table 1 . Complexes were prepared the day before administration and again and coverslipped as described above. either shipped on ice overnight to UC San Francisco for the in vivo dosing or stored at 2-8°C and used for in vitro
In vivo analysis of CFTR expression by RT-PCR experiments at Megabios Corporation. Whenever possReverse transcriptase polymerase chain reaction (RTible, the same batch of complexes was tested in vitro and PCR) assays on whole tissues were performed using vecin vivo. All the complexes were prepared in a solution of tor-specific primers and CFTR-specific primers. The pri-5% dextrose. For the in vivo studies, tissues were harmers used to check for intact mRNA were as follows: for vested 24 or 48 h after dosing. Since the complexes were ␤-2 microglobulin: 5′ ATG TCC TCG ATC CCA GAC delivered to the left lung, the right lung served as an GGT C 3′; 5′ ACC CTG GTC TTT CTG GTG CTT G 3′. internal negative control. CAT expression was measured
The expected size of the PCR product is 340 bp. The vecby a scintillation CAT assay 34 for the following homogentor-specific primers used were as follows: specific for 5′ ization of tissues. All expression data were standardized region of CFTR message: 5′ AGA TCG CCT GGA GAC per milligram of soluble protein present in each sample GCC AT 3′, forward primer (3651-3671bp in pMB113); 5′ which was determined by a Bradford protein assay kit.
GCT CCT AAT GCC AAA GGA AT 3′, reverse primer (1246-1266bp in pMB113, upstream from hCFTR ATG Immunohistochemistry site). For the visualization of gene expression in mice, pathoFor RNA analysis, mice were treated with complexes gen-free 25 g mice were instilled with 100 l of lipid-(3:1, 0.625 mg/ml) of either 4119 for CAT expression or DNA complexes made with p4119. Control mice were pMB113 for CFTR expression. The CAT-treated animals instilled with 100 l of 5% dextrose in water. Forty-eight had one lung analyzed for CAT expression as a positive hours following instillation, the mice were anesthetized, control for delivery (data not shown) and the other lobe the lungs and trachea were removed en bloc, and 50% served as a negative control for CFTR RNA analysis. For ornithine carbamyl transferase (OCT, Miles, Elkhart, IN, RT-PCR, tissues were flash frozen using liquid nitrogen, USA) compound in phosphate-buffered saline was then placed on dry ice and stored at −70°C. Tissue injected through the trachea until the lungs were samples were homogenized and mRNA isolated using expanded to capacity. Tissues were flash frozen, and the Stratagene (La Jolla, CA, USA) RNA isolation kit folstored at −80°C until sectioning. Cryosections 4 m thick lowed by poly A RNA enrichment. Reverse transcriptase were allowed to air dry on silylated slides and were then reactions used either random hexamers or oligo dT fixed in 100% acetone. Sections were incubated with primers. buffer containing 4% normal goat serum and 1% bovine serum albumin (BSA) to block nonspecific binding sites, then incubated with anti-CAT digoxigenin (Boehringer a gold-labeled secondary antibody to digoxigenin cessing group at Megabios Corporation provided the (Boehringer Mannheim) diluted in blocking buffer. After plasmid DNAs and Daisy Leung provided the liposomes. washing again, a silver enhancement was performed with Clayton Bullock helped with the RNA analysis and KrisSilvEnhance LM reagents (Zymed, South San Francisco, tina Walsh was invaluable during the preparation of the CA, USA). For the visualization of reporter gene figures. Rabbit antiserum to rat surfactant protein was a expression and cell type markers in rats, pathogen-free kind gift from Dr Gurmukh Singh, Professor of Pathol-100 g Sprague Dawley male rats were instilled with 300 ogy, Chief of Pathology and Laboratory Medicine Serl of a 1:16 dilution of the 3:1, 0.625 mg/ml EDMPCvice, Department of Veterans Affairs, Medical Center, cholesterol formulation in 5% dextrose in water made University Drive, Pittsburgh PA 15240. The antiserum with p4119. Forty-eight hours following instillation, reacts mainly with rat surfactant protein A. Tim Heath, tissues were prepared and sectioned as described for University of Wisconsin, provided the initial batches of mice. For the simultaneous visualization of CAT EDMPC; subsequent batches were purchased from expression and type I cells, sections were fixed in 100%
Sigma. acetone then blocked with buffer containing 3% BSA. Sections were then incubated with anti-CAT digoxigenin and biotinylated Lycopersicon esculentum lectin (Vector
